Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,676,589
+$134,902 QoQ
Shares Held
10,539
+1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#2,088
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CFO4Life Group, LLC holds $7,374,448 across 8 Drug Manufacturers - General names. JNJ ranks #1 (36.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
10,539 | $2,676,589 | |
| 2 | LLY |
ELI LILLY & Co
|
1,589 | $1,905,894 | |
| 3 | NVS |
Novartis AG
|
4,916 | $770,435 | |
| 4 | AMGN |
Amgen Inc
|
1,340 | $485,240 | |
| 5 | ABBV |
AbbVie Inc.
|
1,745 | $439,111 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,156 | $398,729 | |
| 7 | PFE |
Pfizer Inc
|
15,403 | $370,904 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,549 | $327,546 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,676,589 | 10,539 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,541,687 | 10,398 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,217,469 | 10,715 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,012,734 | 10,855 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,630,759 | 10,676 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,518,099 | 9,154 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,472,810 | 10,184 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,641,829 | 10,131 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,453,415 | 9,944 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,605,628 | 10,150 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,575,863 | 10,054 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,790,034 | 11,493 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $1,957,274 | 11,825 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $1,780,640 | 11,488 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,139,584 | 12,112 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,981,066 | 12,127 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $2,274,435 | 12,813 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $2,219,628 | 12,524 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,059,682 | 12,040 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,014,551 | 12,474 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $1,567,171 | 9,513 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $1,536,508 | 9,349 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $1,515,254 | 9,628 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $1,275,603 | 8,568 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,341,328 | 9,538 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $1,270,256 | 9,687 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||